PAPER Girgenti MJ, Collier E, Sathyanesan M, Su XW, Newton SS
SEARCH RESULTS
331007 RESULTS
PAPER Finnerty JR, Wang WX, Hébert SS, Wilfred BR, Mao G, Nelson PT
The miR-15/107 group of microRNA genes: evolutionary biology, cellular functions, and roles in human diseases.
J Mol Biol. 2010 Sep 24;402(3):491-509. PubMed: 20678503PAPER Frye CA, Walf AA, Paris JJ
Conjugated equine estrogen, with medroxyprogesterone acetate, enhances formation of 5alpha-reduced progestogens and reduces anxiety-like behavior of middle-aged rats.
Behav Pharmacol. 2010 Sep;21(5-6):530-9. PubMed: 20679892PAPER Casteels C, Martinez E, Bormans G, Camon L, de Vera N, Baekelandt V, Planas AM, Van Laere K
Type 1 cannabinoid receptor mapping with [18F]MK-9470 PET in the rat brain after quinolinic acid lesion: a comparison to dopamine receptors and glucose metabolism.
Eur J Nucl Med Mol Imaging. 2010 Dec;37(12):2354-63. PubMed: 20680268PAPER Hsieh Y, Li F, Korfmacher WA
Mapping pharmaceuticals in rat brain sections using MALDI imaging mass spectrometry.
Methods Mol Biol. 2010;656:147-58. PubMed: 20680589α/β-Tubulin
ANTIBODY polyclonal manufacturer Cat# 2148<br />Reference: <br /><a href="/papers/truncated-beta-amyloid-peptide-channels-provide-alternative-mechanism-alzheimers-disease-and" target="_new">Jang, H 2010</a> immunogen = a
Erik Roberson on Aging and excitotoxic stress exacerbate neural circuit reorganization in amyloid precursor protein intracellular domain transgenic mice.
COMMENT This interesting report by Kaushik Ghosal and Sanjay Pimplikar describes seizure-related remodeling in the hippocampus of transgenic mice expressing AICD and the adapter protein Fe65 in excitatory neurons, extending a series of studies from this group on
PAPER Sutula T, Cascino G, Cavazos J, Parada I, Ramirez L
Mossy fiber synaptic reorganization in the epileptic human temporal lobe.
Ann Neurol. 1989 Sep;26(3):321-30. PubMed: 2508534Sarah Monsell
University of WashingtonUnited States
William Jagust on What Do Clinicians Say? Peers Welcome Revised Criteria
COMMENT I was a member of the MCI committee and helped define the biomarker criteria in that draft document, so am biased in this sense. In light of some of the media coverage, a few points seem worth noting: 1. The criteria are designed to be multipurpose, that
Reisa Sperling on What Do Clinicians Say? Peers Welcome Revised Criteria
COMMENT I chaired the Preclinical Alzheimer’s Disease committee. The main confusion in the coverage of this issue so far is that some lay press, perhaps without reading the proposed criteria, made the leap that we were suggesting these criteria for clinical pract
David Holtzman on What Do Clinicians Say? Peers Welcome Revised Criteria
COMMENT There is currently no effective treatment for Alzheimer disease. The new proposed diagnostic criteria for preclinical and very mildly impaired individuals AD are research criteria. They were written to benefit development of new therapeutics so that indiv
Allen Frances on Noisy Response Greets Revised Diagnostic Criteria for AD
COMMENT New Guidelines for Diagnosing Alzheimer's—Wishful Thinking, Dangerous Consequences Previously, I have been quite critical of the DSM-V suggestion to introduce a new diagnosis—Minor Neurocognitive Disorder—on the grounds that it would create a large f
Allen Frances
Duke UniversityUnited States
PAPER Lau AA, Hannouche H, Rozaklis T, Hassiotis S, Hopwood JJ, Hemsley KM
Allogeneic stem cell transplantation does not improve neurological deficits in mucopolysaccharidosis type IIIA mice.
Exp Neurol. 2010 Oct;225(2):445-54. PubMed: 20673764Current Filters
No filters selected